Martina Musella

IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.

Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Assessment of IFN-γ and granzyme-B production by in "sitro" technology.

Cytofluorometric assessment of dendritic cell-mediated uptake of cancer cell apoptotic bodies.

Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.

Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51.

The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition.

The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation.

Actin Cytoskeleton Dynamics and Type I IFN-Mediated Immune Response: A Dangerous Liaison in Cancer?

The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure.

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.

3D cancer models: One step closer to human studies.

Epigenetics behind tumor immunology: a mini review.

Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.

In Vitro Evaluation of Cancer Cell Immunogenicity and Antigen-Specific T-Cell Cytotoxicity by Flow Cytometry.